Skip to main content
Fig. 1 | Trials

Fig. 1

From: The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial

Fig. 1

Design of the PRODICA* trial. Eligible patients are identified at Sahlgrenska University Hospital in Gothenburg, Sweden. An inclusion meeting is scheduled with patients who agree to participate. At the inclusion meeting, participants are randomized to an intervention or a control group, they fill out a questionnaire including a food frequency questionnaire, and blood samples are collected. A 24-h dietary recall is performed with participants about halfway through the study to measure compliance with the intervention. Endpoint blood samples are collected, and participants fill out a similar questionnaire again near the time of the surgery. In immediate adjacency to the surgery, biopsies of cancer and benign prostate tissue are sampled for the study, and the prostate is thereafter handled according to clinical routines. *Impact of DIet and individual genetic factors on tumor proliferation rate in males with PROstate Cancer

Back to article page